Scholar Rock Holding EPS - Earnings per Share 2017-2019 | SRRK

Scholar Rock Holding eps - earnings per share from 2017 to 2019. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Scholar Rock Holding Annual EPS
2018 $-3.15
2017 $-15.30
2016 $-10.11
Scholar Rock Holding Quarterly EPS
Q2 2019 $-0.48
Q1 2019 $-0.42
Q4 2018 $1.86
Q3 2018 $-0.44
Q2 2018 $-1.39
Q1 2018 $-3.18
Q4 2017 $0.00
Q3 2017 $-0.00
Q2 2017 $-3.67
Q4 2016 $0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.266B $0.000B
Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.136B 15.11
CSL (CSLLY) Australia $84.078B 0.00
Gilead Sciences (GILD) United States $81.779B 10.13
Celgene (CELG) United States $77.983B 11.14
Biogen (BIIB) United States $53.075B 9.11
Vertex Pharmaceuticals (VRTX) United States $51.919B 52.99
Illumina (ILMN) United States $43.365B 47.58
Regeneron Pharmaceuticals (REGN) United States $37.813B 16.55
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.123B 11.91
Seattle Genetics (SGEN) United States $18.561B 0.00
Incyte (INCY) United States $18.279B 42.43
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.254B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.531B 0.00
Genmab (GNMSF) Denmark $13.346B 74.86
Exact Sciences (EXAS) United States $10.455B 0.00
Galapagos (GLPG) Belgium $10.396B 26.78
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.307B 0.00
BeiGene (BGNE) Cayman Islands $9.103B 0.00
Bio-Techne Corp (TECH) United States $7.739B 51.80
QIAGEN (QGEN) Netherlands $7.300B 23.80
Sarepta Therapeutics (SRPT) United States $7.065B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.968B 0.00
Guardant Health (GH) United States $6.784B 0.00
Reata Pharmaceuticals (RETA) United States $6.433B 0.00
Amarin (AMRN) Ireland $6.040B 0.00
Moderna (MRNA) United States $5.799B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.621B 14.29
ARGENX SE-ADR (ARGX) Netherlands $4.843B 0.00
Ascendis Pharma (ASND) Denmark $4.773B 0.00
Exelixis (EXEL) United States $4.725B 13.29
China Biologic Products (CBPO) China $4.545B 28.37
Medicines (MDCO) United States $4.414B 0.00
Spark Therapeutics (ONCE) United States $4.287B 0.00
Repligen (RGEN) United States $4.281B 77.58
Mirati Therapeutics (MRTX) United States $4.069B 0.00
Bluebird Bio (BLUE) United States $4.037B 0.00
Adaptive Biotechnologies (ADPT) United States $3.520B 0.00
Blueprint Medicines (BPMC) United States $3.492B 0.00
MorphoSys AG (MOR) Germany $3.378B 0.00
Immunomedics (IMMU) United States $3.326B 0.00
Alkermes (ALKS) Ireland $3.130B 0.00
Genmab (GMAB) Denmark $2.853B 5.88
CRISPR Therapeutics AG (CRSP) Switzerland $2.810B 0.00
Emergent Biosolutions (EBS) United States $2.775B 27.56
Intercept Pharmaceuticals (ICPT) United States $2.683B 0.00
MyoKardia (MYOK) United States $2.563B 0.00
Halozyme Therapeutics (HALO) United States $2.429B 0.00
NeoGenomics (NEO) United States $2.378B 127.22
Acceleron Pharma (XLRN) United States $2.366B 0.00
Amicus Therapeutics (FOLD) United States $2.363B 0.00
UniQure (QURE) Netherlands $2.344B 0.00
Arena Pharmaceuticals (ARNA) United States $2.306B 5.40
Zai Lab (ZLAB) China $2.289B 0.00
RA PHARMCTL INC (RARX) United States $2.202B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.166B 0.00
Ligand Pharmaceuticals (LGND) United States $2.070B 36.79
Cambrex (CBM) United States $2.016B 25.44
Akcea Therapeutics (AKCA) United States $1.819B 0.00
Myriad Genetics (MYGN) United States $1.803B 26.64
Insmed (INSM) United States $1.690B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.583B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.467B 0.00
Denali Therapeutics (DNLI) United States $1.426B 0.00
REGENXBIO (RGNX) United States $1.418B 0.00
Zymeworks (ZYME) Canada $1.369B 0.00
Epizyme (EPZM) United States $1.353B 0.00
Coherus BioSciences (CHRS) United States $1.312B 0.00
Innoviva (INVA) United States $1.238B 3.65
Dicerna Pharmaceuticals (DRNA) United States $1.227B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.153B 0.00
Alector (ALEC) United States $1.148B 0.00
Zealand Pharma (ZLDPF) Denmark $1.143B 0.00
Sangamo Therapeutics (SGMO) United States $1.134B 0.00
Fate Therapeutics (FATE) United States $1.096B 0.00
Zealand Pharma (ZEAL) Denmark $1.044B 11.72
Editas Medicine (EDIT) United States $1.010B 0.00
WAVE Life Sciences (WVE) Singapore $0.926B 0.00
Codexis (CDXS) United States $0.894B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.889B 0.00
Athenex (ATNX) United States $0.880B 0.00
Arvinas (ARVN) United States $0.868B 0.00
Anika Therapeutics (ANIK) United States $0.859B 27.88
Vericel (VCEL) United States $0.856B 319.17
Cara Therapeutics (CARA) United States $0.851B 0.00
Pharming Group (PHGUF) Netherlands $0.799B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.794B 6.67
Principia Biopharma (PRNB) United States $0.768B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.760B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.734B 0.00
Twist Bioscience (TWST) United States $0.716B 0.00
Heska (HSKA) United States $0.700B 178.74
DBV Technologies S.A (DBVT) France $0.699B 0.00
ANI Pharmaceuticals (ANIP) United States $0.694B 11.83
Revance Therapeutics (RVNC) United States $0.682B 0.00
MiMedx (MDXG) United States $0.649B 0.00
Intellia Therapeutics (NTLA) United States $0.634B 0.00
GENFIT S.A (GNFT) France $0.630B 0.00
Mesoblast (MESO) Australia $0.618B 0.00
Adverum Biotechnologies (ADVM) United States $0.591B 0.00
Cellectis S.A (CLLS) France $0.576B 0.00
Retrophin (RTRX) United States $0.549B 0.00
Agenus (AGEN) United States $0.536B 0.00
BioDelivery Sciences (BDSI) United States $0.523B 0.00
Intra-Cellular Therapies (ITCI) United States $0.514B 0.00
UROGEN PHARMA (URGN) United States $0.506B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.491B 0.00
Cytokineticsorporated (CYTK) United States $0.482B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
PHARMA MAR SA (PHMMF) Spain $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Precision BioSciences (DTIL) United States $0.431B 0.00
Stemline Therapeutics (STML) United States $0.429B 0.00
Kadmon Holdings (KDMN) United States $0.388B 0.00
AC Immune SA (ACIU) Switzerland $0.382B 28.30
Lexicon Pharmaceuticals (LXRX) United States $0.377B 2.61
Merus (MRUS) Netherlands $0.375B 0.00
Dynavax Technologies (DVAX) United States $0.369B 0.00
Prothena (PRTA) Ireland $0.365B 0.00
Bellus Health (BLU) Canada $0.358B 0.00
Arcus Biosciences (RCUS) United States $0.350B 0.00
Cellular Biomedicine (CBMG) United States $0.345B 0.00
Puma Biotechnology (PBYI) United States $0.332B 0.00
PDL BioPharma (PDLI) United States $0.331B 8.29
Pfenex (PFNX) United States $0.331B 0.00
Kindred Biosciences (KIN) United States $0.330B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.314B 0.00
Theratechnologies (THTX) Canada $0.302B 0.00
Geron (GERN) United States $0.296B 0.00
Clovis Oncology (CLVS) United States $0.295B 0.00
Protagonist Therapeutics (PTGX) United States $0.287B 0.00
Avid Bioservices (CDMO) United States $0.286B 0.00
AnaptysBio (ANAB) United States $0.281B 0.00
Compugen (CGEN) Israel $0.279B 0.00
Gritstone Oncology (GRTS) United States $0.268B 0.00
ADMA Biologics Inc (ADMA) United States $0.260B 0.00
Seres Therapeutics (MCRB) United States $0.255B 0.00
CytomX Therapeutics (CTMX) United States $0.254B 0.00
Biofrontera AG (BFRA) Germany $0.253B 378.53
Sutro Biopharma (STRO) United States $0.250B 0.00
Inovio Pharmaceuticals (INO) United States $0.243B 0.00
Cel-Sci (CVM) United States $0.240B 0.00
MannKind (MNKD) United States $0.235B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.234B 0.00
Albireo Pharma (ALBO) United States $0.234B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Sorrento Therapeutics (SRNE) United States $0.223B 0.00
Kamada (KMDA) Israel $0.215B 8.23
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
XOMA (XOMA) United States $0.212B 0.00
Syros Pharmaceuticals (SYRS) United States $0.212B 0.00
Cue Biopharma (CUE) United States $0.206B 0.00
Athersys (ATHX) United States $0.204B 0.00
Spero Therapeutics (SPRO) United States $0.201B 0.00
OSMOTICA PHARM (OSMT) United States $0.198B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.195B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.189B 0.00
Exicure (XCUR) United States $0.186B 0.00
Palatin Technologies (PTN) United States $0.185B 5.43
Senesco Technologies (ELOX) United States $0.180B 0.00
Arsanis (XFOR) United States $0.177B 0.00
ChromaDex (CDXC) United States $0.170B 0.00
Affimed (AFMD) Germany $0.162B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Cerecor (CERC) United States $0.148B 0.00
Prometic Life Sciences (PFSCF) Canada $0.146B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.144B 0.00
Five Prime Therapeutics (FPRX) United States $0.143B 0.00
Ophthotech (ISEE) United States $0.141B 0.00
CorMedix Inc (CRMD) United States $0.140B 0.00
Alcobra (ARCT) United States $0.139B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.138B 0.00
Emmaus Life Sciences (EMMA) United States $0.135B 0.00
Enzo Biochem (ENZ) United States $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.126B 0.00
Abeona Therapeutics (ABEO) United States $0.123B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Menlo Therapeutics (MNLO) United States $0.116B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
SESEN BIO, INC (SESN) United States $0.113B 0.00
NantKwest (NK) United States $0.112B 0.00
PHASEBIO PHARMA (PHAS) United States $0.111B 0.00
Aptinyx (APTX) United States $0.111B 0.00
BioTime (LCTX) United States $0.109B 7.30
Mersana Therapeutics (MRSN) United States $0.107B 0.00
Acorda Therapeutics (ACOR) United States $0.105B 0.00
Fortress Biotech (FBIO) United States $0.104B 0.00
Novavax (NVAX) United States $0.104B 0.00
OvaScience (MLND) United States $0.104B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
Strongbridge Biopharma (SBBP) United States $0.093B 2.48
Antibe Therapeutics (ATBPF) Canada $0.091B 0.00
Aduro Biotech (ADRO) United States $0.090B 0.00
Celyad SA (CYAD) Belgium $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.084B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.083B 0.00
Arbutus Biopharma (ABUS) Canada $0.082B 0.00
Verastem (VSTM) United States $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
VTv Therapeutics (VTVT) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Synlogic (SYBX) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.069B 0.00
Checkpoint Therapeutics (CKPT) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.068B 0.00
Trevena (TRVN) United States $0.068B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Selecta Biosciences (SELB) United States $0.063B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.058B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Orgenesis (ORGS) United States $0.056B 3.65
Pluristem Therapeutics (PSTI) Israel $0.053B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Merrimack Pharmaceuticals (MACK) United States $0.052B 0.00
Proteostasis Therapeutics (PTI) United States $0.051B 0.00
Organovo Holdings (ONVO) United States $0.050B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.044B 0.00
Evogene (EVGN) Israel $0.041B 0.00
Unum Therapeutics (UMRX) United States $0.036B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
Oncobiologics (OTLK) United States $0.034B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.032B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.95
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.028B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.028B 0.00
Entera Bio (ENTX) Israel $0.028B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Celsion (CLSN) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Soligenix (SNGX) United States $0.022B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.021B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Alimera Sciences (ALIM) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.004B 0.00
Neuralstem (SNCA) United States $0.002B 0.00